Posts archive for October, 2024

Healthline, New Delhi, September 2024: Recent research indicates that glucagon-like peptide-1 (GLP-1) receptor agonist drugs, such as Ozempic and Mounjaro, could prevent up to 34,000 heart attacks and strokes annually in the U.S. These medications, traditionally used for diabetes and obesity, have demonstrated cardiovascular benefits in previous trials for individuals […]

Healthline, New Delhi, September 2024: A study published in Neurology reveals that the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, which combines the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet, can slow cognitive decline, particularly in women. This new research has shown that adherence to the […]